Tengion IncTengion Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The Sustainability rating for Tengion Inc represents the company's reporting of the UN SDGs. This article includes a questions and answers section about Tengion Inc. This Disclosure score includes 17 UN Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Life on Land'.

Tengion Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.

SDG Transparency Score for Tengion Inc 

0.0

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Tengion Inc 
0.0

Environmental

0.0

Social

0.0

Governance

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1967Hospira Inc
0.3
Low
1967PRA Health Sciences Inc
0.3
Low
1970Tengion Inc
0.0
Low
1970CSPC Innovation Pharmaceutical Co Ltd
0.0
Low
1970CTC Bio Inc
0.0
Low
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........

Frequently Asked Questions

Does Tengion Inc have an accelerator or VC vehicle to help deliver innovation?
Does Tengion Inc disclose current and historical energy intensity?
Does Tengion Inc report the average age of the workforce?
Does Tengion Inc reference operational or capital allocation in relation to climate change?
Does Tengion Inc disclose its ethnicity pay gap?
Does Tengion Inc disclose cybersecurity risks?
Does Tengion Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Tengion Inc offer flexible work?
Does Tengion Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Tengion Inc disclose the number of employees in R&D functions?
Does Tengion Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Tengion Inc conduct supply chain audits?
Does Tengion Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Tengion Inc conduct 360 degree staff reviews?
Does Tengion Inc disclose the individual responsible for D&I?
Does Tengion Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Tengion Inc disclose current and / or historical scope 2 emissions?
Does Tengion Inc disclose water use targets?
Does Tengion Inc have careers partnerships with academic institutions?
Did Tengion Inc have a product recall in the last two years?
Does Tengion Inc disclose incidents of discrimination?
Does Tengion Inc allow for Work Councils/Collective Agreements to be formed?
Has Tengion Inc issued a profit warning in the past 24 months?
Does Tengion Inc disclose parental leave metrics?
Does Tengion Inc disclose climate scenario or pathway analysis?
Does Tengion Inc disclose current and / or historical scope 1 emissions?
Does Tengion Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Tengion Inc disclose the pay ratio of women to men?
Does Tengion Inc support suppliers with sustainability related research and development?
Does Tengion Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Tengion Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Tengion Inc involved in embryonic stem cell research?
Does Tengion Inc disclose GHG and Air Emissions intensity?
Does Tengion Inc disclose its waste policy?
Does Tengion Inc report according to TCFD requirements?
Does Tengion Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Tengion Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Tengion Inc disclose energy use targets?
Does Tengion Inc disclose its Renewable Energy targets?
Are emissions metrics verified by STBi?
Does Tengion Inc have a policy relating to cyber security?

Potential Risks for Tengion Inc
These potential risks are based on the size, segment and geographies of the company.

Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which is in Phase I clinical trial and used to replace the use of bowel tissue in bladder cancer patients requiring a non-continent urinary diversion after bladder removal surgery. The company has a license agreement with Children's Medical Center Corporation (CMCC) for the license of certain patent rights and intellectual property rights owned or controlled by CMCC related to tissue engineering technology. Tengion, Inc. was founded in 2003 and is headquartered in Winston-Salem, North Carolina. On December 29, 2014, Tengion, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Sorry!

Failed to process!